Contribution of changes in population aging, population growth, and age-specific incidence rate to changes in incident cases of LC from 2004 to 2018 in China. by Ze-Xing Zhang (18074512)

Subjects:

Period-specific relative risks (RRs) for CRC burden by sex in East Asian countries, the United States, and globally, based on the age-period-cohort model. by Yuanyi Cao (22394797)

Subjects:

The cases and age-standardised rates (per 100,00 population) of CRC incidence, mortality and DALYs by sex in East Asian countries, the United States, and globally in 1990 and 2021. by Yuanyi Cao (22394797)

Subjects:

Age-specific relative risks (RRs) for CRC burden by sex in East Asian countries, the United States, and globally, based on the age-period-cohort model. by Yuanyi Cao (22394797)

Subjects:

Association between age-standardised CRC burden metrics (ASIR, ASMR, ASDR) and the Socio-Demographic Index (SDI) in five East Asian countries (1990-2021). by Yuanyi Cao (22394797)

Subjects:

Cohort-specific relative risks (RRs) for CRC burden by sex in East Asian countries, the United States, and globally, based on the age-period-cohort model. by Yuanyi Cao (22394797)

Subjects:

Decomposition of changes in the number of CRC burden in East Asian countries, the United States, and globally, 1990–2021. by Yuanyi Cao (22394797)

Subjects:

Joinpoint regression analysis of the trends in age-standardised rates of CRC burden in five East Asian countries, the United States, and globally, 1990–2021. by Yuanyi Cao (22394797)

Subjects:

Column charts of WiAUC in therapy and control group at baseline and follow-up. by Felix L. Herr (21544362)

Forest plot between UCAR and cognitive impairment. by Yubo Teng (21246745)

Subjects:

Flowchart of participants in this study. by Yubo Teng (21246745)

Subjects:

Nonlinear relationship between UACR and cognitive impairment. by Yubo Teng (21246745)

Subjects:

Threshold effect analysis of UACR and cognitive impairment. by Yubo Teng (21246745)

Subjects:

Analyzing the relationship between UACR (<30) and cognitive scores and impairment. by Yubo Teng (21246745)

Subjects:

Analyzing the relationship between UACR and cognitive scores and impairment. by Yubo Teng (21246745)

Subjects:

Baseline characteristics of participants (N = 2385) by UACR. by Yubo Teng (21246745)

Subjects:

Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

“…Among the letrozole-treated patients, the mean FIB-4 index tended to decline during letrozole treatment; a significant decrease was observed at 18 and 24 months compared with the baseline values (p = 0.044 and p = 0.013). …”

S1 Data - by Kazuyoshi Ohkawa (836847)

“…Among the letrozole-treated patients, the mean FIB-4 index tended to decline during letrozole treatment; a significant decrease was observed at 18 and 24 months compared with the baseline values (p = 0.044 and p = 0.013). …”

Annual treatment frequencies in all eyes. by Yasuyuki Sotani (20114144)

“…<p>The number of anti-VEGF treatments, STTA, MA-PC, PPV, and total treatments (mean ± SD) significantly decreased from 2.6 ± 1.6, 0.3 ± 0.8, 0.6 ± 0.8, 0.1 ± 0.3, and 3.7 ± 1.7 preoperatively to 0.8 ± 1.9, 0.0 ± 0.2, 0.3 ± 1.0, 0.0, and 1.2 ± 2.2; at year 2 to 0.7 ± 2.0, 0.1 ± 0.6, 0.0 ± 0.2, 0.0 ± 0.2, and 1.0 ± 2.1; and at year 3 to 0.9 ± 2.2, 0.0, 0.2 ± 1.0, 0.0 ± 0.2, and 1.1 ± 3.1 (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)